- 基本信息
|
导师姓名：
|
韩宝惠
|
学科代码：
|
100201
|
|
|
性别：
|
男
|
学科名称：
|
内科学
|
|
培养单位：
|
附属胸科医院
|
三级学科
|
呼吸系病
|
|
导师类型：
|
博士生导师
|
专业领域名称：
|
内科学 专业学位
|
|
联系方式：
|
|
专业领域代码：
|
105101
|
|
邮编：
|
|
邮箱地址：
|
hanxkyy@aliyun.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
| |
|
上海医学杂志编委
|
|
中华结核与呼吸杂编委
|
|
美国肿瘤临床协会会员
|
|
循证医学杂志编委
|
|
临床肿瘤学杂志编委
|
|
中国肺癌杂志编委
|
|
国际呼吸病杂志编委
|
|
CSCO肿瘤血管靶向专业委员会主委
|
|
中华医学生物免疫治疗学会副会长
|
|
中国肿瘤年鉴肺癌专辑专家
|
|
上海市卫生系统高级职称评审委员会委员
|
|
中国抗癌学会上海分会胸部肿瘤专业委员会 副主任委员
|
|
上海市欧美同学会医学部理事兼副秘书长
|
|
中华临床医学杂志编委
|
|
上海交通大学学报（医学版）杂志编委
|
|
卫生部内镜专业培训基地主任
|
|
中国肿瘤临床多中心学会执行委员
|
|
上海市医疗事故专家鉴定委员会委员
|
|
上海市抗癌协会副理事长
|
|
中华肺癌学院 执行院长
|
|
中国肿瘤年鉴肺癌靶向治疗特邀专家
|
|
上海市卫生系统高级专业技术职务任职资格评审委员会委员暨内二科组长
|
|
中华医学生物免疫学会肿瘤分会 主任委员
|
|
中国癌症基金会控烟与肺癌防治办公室副主任
|
|
国家自然科学基金委函审专家
|
|
肺癌专业委员会委员
|
|
中华医学会上海分会肺科专科委员会委员，肺癌组组长（卸任）
|
|
上海市呼吸病研究所肺癌早诊和转移防治基地副主任
|
|
上海市医学会肿瘤靶分子专委会 副主任委员
|
|
肿瘤年鉴 肺癌专刊 中国版 主编
|
|
癌症进展杂志 编委
|
|
中华肿瘤防治杂志编委
|
|
国际肺癌协会会员
|
|
中国老年学会老年肿瘤学会执行委员
|
|
中国医师协会肿瘤分会常委
|
|
肿瘤杂志编委
|
|
中国肿瘤临床协作协会（CSCO）非小细胞肺癌专委会副主任委员
|
|
上海市卫生局呼吸病质控中心专家组成员
|
|
中国抗癌协会肿瘤精准诊疗专委会 副主任委员
|
|
中华临床肿瘤杂志编委
|
|
中国医师学会呼吸分会委员
|
|
中国中西医结合学会呼吸学会 副主任委员
|
- 科研项目
| WJW---126 | 卫健委临床重点专科：呼吸内科建设 | 上海市卫健委 |
2019-06~2022-06
|
170万元
| 课题负责人 |
| xkxt--20190102 | 基于二代测序为基础的肺癌精准个体化治疗 | 上海市胸科医院发展基金 |
2019-01~2022-01
|
200万元
| 课题负责人 |
| XHLHGG201805 | 基于影像学方法筛查社区早期肺癌的应用研究 | 上海市徐汇区卫生局 |
2018-06~2020-06
|
100万元
| 课题负责人 |
| | 引导支气管镜技术在肺外周病变诊治中的应用 | 上海申康医院发展中心 |
2015-11~2018-10
|
100万元
| 课题负责人 |
| | 基于外周血肺内微小结节的精准诊断的探索研究 | 上海交通大学2011系统生物医学协同创新中心课题 |
2015-09~2017-08
|
30万元
| 课题负责人 |
| 15ZH1008 | EGFR突变肺腺癌TKI耐药复发相关早期生物标志物的探索性研究 | 上海交通大学医学院转化医学创新基金重点项目 |
2015-06~2017-05
|
20万元
| 课题负责人 |
| 2013ZYJB0402 | 基于影像学方法筛查社区早期肺癌的应用研究 | 上海卫生系统重要疾病联合攻关项目-重大项目 |
2014-01~2016-12
|
150万元
| 课题负责人 |
| | | 2013上海领军人才 |
2013-01~2013-12
|
25万元
| 课题负责人 |
| | 肿瘤药物临床研究平台 | “985” 转化医学平台建设子课题 |
2012-01~
|
30万元
| 课题负责人 |
| 11411951200 | EGFR敏感突变肺腺癌不同治疗策略的对照研究及非小细胞肺癌早期诊断和治疗优化方案研究 | 上海市科委重点课题 |
2012-01~2013-01
|
50万元
| 课题负责人 |
| 11JC1412200 | 血清DKK1水平在非小细胞肺癌早期诊断、铂类化疗疗效预测和监测中的作用研究 | 上海市科委重点基础课题 |
2012-01~2013-12
|
40万元
| 课题负责人 |
| 81172104 | 跨损伤合成修复通路TLS基因多态性与NSCLC含铂化疗疗效的关联分析
| 国家自然科学基金 |
2011-04~2014-04
|
60万元
| 课题负责人 |
| SHDC12010101 | 超声支气管镜引导下的经支气管针吸活检（EBUS-TBNA）在肺癌诊治中的应用 | 上海申康医院发展中心 |
2010-05~2012-04
|
240万元
| 课题负责人 |
| SHDC12010804 | 市级医院中心实验室建设 | 上海申康医院发展中心 |
2010-05~2012-04
|
200万元
| 课题负责人 |
- 学术论文
|
Yang W,, Teng J, Wang H, Manegold C, Pilz LR, Voigt W, Zhang Y, Ye J,
Chen Q, Han B; Written on behalf of the AME Thoracic Surgery Collaborative Group.
|
Community-based lung cancer screening with low-dose CT in China: Results of the
|
Lung Cancer
|
2018
|
117:20-26
|
|
Zhang B, Zhang Y, Xu J, Zhang X, Chu T, Wang S, Qian J, Qiao R, Lu J,, Han B
|
Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced
|
Target Oncol
|
2018
|
13(5):631-639
|
|
Qian J, Zhang X, Zhang B, Gu P, Wang L,
|
Hepatotoxicity in Advanced Lung Adenocarcinoma: A Retrospective Study of 2108 Cases
|
J Cancer.
|
2018
|
9:1607-1613.
|
|
Wang S, Xu J, Wang R, Qian F, Yang W, Qiao R, Zhang B, Qian J, Yu K,
|
Adjuvant chemotherapy may improve prognosis after resection of stage I lung
|
J Thorac Cardiovasc Surg.
|
2018
|
156(5):2006-2015.
|
|
, Yang L, Wang X, Yao L.
|
Efficacy of pemetrexed-based regimens in advanced non-small cell lung cancer patients with activating epidermal growth
|
Onco Targets Ther
|
2018
|
12;11:2121-2129
|
|
Wang Y, Zheng D, Zheng J, Huang Q,, Zhang J, Zhao H, Chen H. . . 2018 Jun;
|
Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma
|
J Cancer Res Clin Oncol
|
2018
|
144(6):1015-1023
|
|
Wang S, Zhang B, Qian J, Qiao R, Xu J, Zhang L, Zhao Y, Zhang Y, Wang R, Zhao R,
|
Proposal on incorporating lymphovascular invasion as a T-descriptor for
|
LUNG CANCER
|
2018
|
125:245-252.
|
|
Xiong L, Li R, Sun J, Lou Y, Zhang W, Bai H, Wang H, Shen J, Jing B, Shi C,Zhong H, Gu A, Jiang L, Shi J, Fang W, Zhao H, Zhang J, Wang J, Ye J,
|
Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation-Positive
|
Oncologist
|
2018
|
24(2):157-e64.
|
|
Qian F, Yang W, Chen Q, Zhang X,
|
Screening for early stage lung cancer and its correlation with lung nodule detection.
|
J Thorac Dis
|
2018
|
10(Suppl7):S846-S859.
|
|
Sun C, Zhang Z, Qie J, Wang Y, Qian J, Wang J, Wu J, Li Q, Bai C, Han B,, Xu J, Lu D, Jin L, Wang H.
|
Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer
|
Oncotarget
|
2018
|
9(35):23860-23877
|
|
Wang Y, Xu J,, Luo Q, Zhao H, Lv C, Wang J, Liu J, Fu X.
|
The role of
|
J Thorac Dis.
|
2018
|
;10(6):3418-3427
|
|
Zhang B, Xu J, Zhang X, Gu P, Wang H, Wang S, Qian J, Qiao R, Zhang Y, Yang W,, Zhou Y, Lu J, Zhang L, Han B 15
|
Coexistence of sensitive and resistant epidermal growth factor receptor (EGFR) mutations in pretreatment non-small cell
|
Lung Cancer
|
2018
|
117:27-31.
|
|
Yang JC, Mok T,, Orlando M, Puri T, Park K
|
A Review of Regimens
|
Clin Lung Cancer
|
2018
|
19(1):27-34
|
|
Ouyang X, Shi M, Jie F, Bai Y, Shen P, Yu Z, Wang X, Huang C, Tao M, Wang Z, 14Xie C, Wu Q, Shu Y,, Zhang F, Zhang Y, Hu C, Ma X, Liang Y, Wang A, Lu B,
Shi Y, Chen J, Zhuang Z, Wang J, Huang J, Wang C, Bai C, Zhou X, Li Q, Chen F, Yu H, Feng J
|
Phase III study of dulanermin (recombinant human tumor necrosis
|
Invest New Drugs
|
2018
|
36(2):315-322
|
|
, Li K, Zhao Y, Li B, Cheng Y, Zhou J, Lu Y, Shi Y, Wang Z, Jiang L, Luo Y, Zhang Y, Huang C, Li Q, Wu G. 2018 Mar 6;
|
Anlotinib as a third-line therapy in patients
|
Br J Cancer
|
2018
|
118(5):654-661
|
|
Zhang B, Wang S, Qian J, Yang W, Qian F, Lu J, Zhang Y, Qiao R,
|
Complex epidermal growth factor receptor mutations and their responses to
|
Cancer
|
2018
|
124(11):2399-2406.
|
|
Yang W, Sun Y, Fang W, Qian F, Ye J, Chen Q, Jiang Y, Yu K,
|
High-resolution Computed Tomography Features Distinguishing Benign and Malignant
|
Clin Lung Cancer
|
2018
|
19(1):e75-e83
|
|
Lu J,
|
Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision
|
Technol Cancer Res Treat
|
2018
|
17:1533033818801809
|
|
Zhou Y, Shurin GV, Zhong H, Bunimovich YL,, Shurin MR.
|
Schwann Cells Augment Cell Spreading and Metastasis of Lung Cancer.
|
Cancer Res
|
2018
|
15;78(20):5927-5939
|
|
, Kai Li, et al
|
Anlotinib as third-line or further-line treatment in advanced non-small cell lung cancer (ALTER 0303): a multicentre, randomized, double-blind phase 3 trial
|
JAMA Oncology
|
2018
|
9/8 2018 online
|
|
Si X, Zhang L, Wang H, Zhang X, Wang M,, Li K, Wang Q, Shi J, Wang Z,Cheng Y, He J, Shi Y, Chen W, Wang X, Luo Y, Nan K, Jin F, Li B, Chen Y, Zhou J,
Wang D. Quality of life results from a randomized, double-blinded,
placebo-controlled, multi-center phase III trial of anlotinib in patients with
advanced non-small cell lung cancer.
|
Quality of life results from a randomized, double-blinded,placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer
|
Lung Cancer.
|
2018
|
122:32-37
|
|
Zhang X, Zhang Y, Xu J, Wang H, Zheng X, Lou Y,
|
Antigen presentation
|
J Cancer
|
2018
|
9(2):367-374
|
|
Yang H, Wang S, Teng J,, Sun J
|
Utility of endobronchial
|
Clin Respir J
|
2018
|
12(2):691-698
|
|
Qian F, Yang W, Wang R, Xu J, Wang S, Zhang Y, Jin B, Yu K,
|
Prognostic
|
Thorac Cardiovasc Surg
|
2018
|
155(3):1227-1235
|
|
Yu X, Li Y, Shi C,
|
Risk factors of lymph node metastasis in patients
|
Thorac Cancer
|
2017
|
9(1):3-9
|
|
YU DONG, WEIHONG REN,JUN QI, BO JIN, YING LI, HUIQING TAO, REN XU,YANQING LI, QINXIAN ZHANG,
|
EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer
|
Oncol Lett.
|
2016
|
2016 Apr; 11(4): 2371–2378.
|
|
Jianlin Xu,Yanwei Zhang,Bo Jin,Tianqing Chu,Xue Dong,Haitang Yang,Dan Wu,Yuqing Lou,Xueyan Zhang,Huiming Wang,
|
Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations in China
|
Journal of Cancer Research and Clinical Oncology
|
2016
|
Volume 142, Issue 6, pp 1325–1330
|
|
Hao Bai,Jianlin Xu, Haitang Yang, Bo Jin, Yuqing Lou, Dan Wu,
|
Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy
|
Onco Targets Ther.
|
2016
|
9: 4207–4213
|
|
MeiLi Ma, ChunLei Shi, JiaLin Qian, JiaJun Teng, Hua Zhong,
|
Comparison of plasma and tissue samples in epidermal growth factor receptor mutation by ARMS in advanced non-small cell lung cancer
|
Gene
|
2016
|
591, Issue 1, 10 October 2016, 58–64
|
|
Rong Li, Xia Pu, Joe Y. Chang, Yuanqing Ye, Ritsuko Komaki,John D. Minna,Jack A. Roth,
|
MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non–Small Cell Lung Cancer
|
PLoS One.
|
2016
|
2016; 11(3): e0150467.
|
|
Jiayuan Sun, Xiaowei Mao, Fangfang Xie,
|
Electromagnetic navigation bronchoscopy guided injection of methylene blue combined with hookwire for preoperative localization of small pulmonary lesions in thoracoscopic surgery
|
J Thorac Dis
|
2016
|
7(12): E652–E656.
|
|
Martin Reck, Koichi Hagiwara,, Sergei Tjulandin,Christian Grohé, Takashi Yokoi, Alessandro Morabito, Silvia Novello, Edurne Arriola, Olivier Molinier, Rose McCormack, Marianne Ratcliffe,Nicola Normanno, MDl,
|
ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study
|
Journal of Thoracic Oncology
|
2016
|
10.1016/j.jtho.2016.05.036
|
|
Yuqing Lou,Yanwei Zhang,Rong Li,Ping Gu,Liwen Xiong,Hua Zhong,Wei Zhang,
|
Transcriptional profiling revealed the anti-proliferative effect of MFN2 deficiency and identified risk factors in lung adenocarcinoma
|
Tumor Biology
|
2016
|
pp 1–13
|
|
Jianlin Xua, Bo Jina, Tianqing Chua, Xue Dong, Haitang Yang, Yanwei Zhang, Dan Wu, Yuqing Lou, Xueyan Zhang, Huiming Wang,
|
EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China
|
Lung Cancer
|
2016
|
96, June 2016, Pages 87–92
|
|
J. L. Xu, B. Jin, Z. H. Ren, Y. Q. Lou, Z. R. Zhou,Q. Z. Yang,
|
Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
|
PLOS ONE
|
2015
|
10(7):e0131278
|
|
Runbo Zhong , Xiaoxiao Ge , Tianqing Chu, Jiajun Teng, Bo Yan, Jun Pei, Liyan Jiang, Hua Zhong,
|
Lentivirus-mediated knockdown of CTDP1 inhibits lung cancer cell growth in vitro
|
J Cancer Res Clin Oncol
|
2015
|
pp 1-10
|
|
Zhang W.a ,Zhang T.b ,Lou Y.a ,Yan B.a , Cui S.a , Jiang L.a ,
|
Placental Growth Factor Promotes Metastases of Non-Small Cell Lung Cancer Through MMP9
|
Cellular physiology and biochemistry
|
2015
|
37(3):1210-8
|
|
Xueyan Zhang , Yuqing Lou , Huimin Wang, Xiaoxuan Zheng, Qianggang Dong, Jiayuan Sun,
|
Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells
|
Medical Oncology
|
2015
|
32(4):95
|
|
jiayuan SUN, Liang BAO, Jiajun TENG, Runbo ZHONG, Weiqiong WENG, Qin ZHANG,
|
气管内超声引导下经支气管针吸活检?在肺外肿瘤胸内转移中的诊断价值
|
中国肺癌杂志
|
2015
|
18(5):295-300
|
|
Xiaofei Wang, Dongliang Xu, Yueling Liao, Shuangshuang Zhong, Hongyong Song, Beibei Sun, Binhua P. Zhou, Jiong Deng,
|
Epithelial neoplasia coincides with exacerbated injury and fibrotic response in the lungs of Gprc5a-knockout mice following silica exposure
|
Oncotarget
|
2015
|
6(37):39578-93
|
|
Jiayuan Sun,Hui zhen Yang,Jiajun Teng,Zhang J,Zhao H,Garfield DH,
|
Determining factors in diagnosing pulmonary sarcoidosis by endobronchial ultrasound-guided transbronchial needle aspiration
|
Annals of Thoracic Surgery
|
2015
|
99(2):441-5
|
|
Keke Yu, Jie Zhang, Xin Li, Lei Xu, Ye Zhang, Jie Xing, Jinchen Shao,Lei Zhu,Jinguo Liu, Lanxiang Zhao,
|
Establishment and management of a lung cancer biobank in Eastern China
|
Thorac Cancer
|
2015
|
6(1): 58–63
|
|
Yuqing Lou , Rong Li , Jielin Liu, Yanwei Zhang, Xueyan Zhang, Bo Jin, Ya Liu, Zuoguang Wang, Hua Zhong, Shaojun Wen,
|
Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma
|
Medical Oncology
|
2015
|
32(4):132
|
|
Aiqin Gu, Jianhong Lu, Weimin Wang, Chunlei Shi,, Ming Yao
|
Role of miR-497 in VEGF-A-mediated cancer cell growth and invasion in non-small cell lung cancer
|
Int J Biochem Cell Biol
|
2015
|
70:118-125
|
|
Zhang Xueyan,Wang Huimin,LOu Yuqing,Jin Bo,
|
肺腺癌组织中B细胞特异性莫洛氏鼠白血病病毒插入位点基因1表达与患者临床指标及预后的相关性
|
《中国医药》
|
2014
|
9(1):32-36
|
|
S Chunlei,Q Jialin,M Meili,Z Yanwei,
|
Notch 3 Protein, not its Gene Polymorphism, is Associated with the Chemotherapy Response and Prognosis of Advanced NSCLC Patients
|
Cell Physiol Biochem
|
2014
|
33
|
|
Yuqing Lou, Rong Li, Yanwei Zhang, Runbo Zhong, Jun Pei, Liwen Xiong, Xueyan Zhang ,
|
XPA gene rs1800975 single nucleotide polymorphism and lung cancer risk: a meta-analysis
|
Tumor Biology
|
2014
|
5(7):6607-17
|
|
Jin Bo,Zhang Yanwei,Zhang Xueyan,Li Rong,Lou Yuqing,Niu Yanjie,
|
外周血癌胚抗原水平与晚期非小细胞肺癌患者EGFR-TKI疗效的相关性
|
《中华医学杂志》
|
2014
|
94(30):2327-2331
|
|
Yanwei Zhang, Bo Jin, Minhua Shao, Yu Dong, Yuqing Lou, Aimi Huang,
|
Monitoring of carcinoembryonic antigen levels is predictive of EGFR mutations and efficacy of EGFR-TKI in patients with lung adenocarcinoma
|
Tumor Biology
|
2014
|
35(5):4921-8
|
|
Minhua Shao, Bo Jin, Yanjie Niu, Junyi Ye, Daru Lu,
|
Association of POLK Polymorphisms with Platinum-Based Chemotherapy Response and Severe Toxicity in Non-small Cell Lung Cancer Patients
|
Cell Biochem Biophys
|
2014
|
70:1227–1237
|
|
Xueyan, Zhang, Jiayuan Sun, Huimin, Wang, Yuqing,, Yanwei Zhang, Huifang,S.,Han Baohui
|
IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance
|
Tumor Biology
|
2014
|
35(1):739-745
|
|
Xia Jinjing,Bai Hao, Xiong Liwen,Li Rong,Yan Bo,Shao Minhua,
|
高分辨率熔解曲线法在BIM基因2,903bp片段插入/缺失检测中的应用
|
《中国肺癌杂志》
|
2014
|
17(3):238-242
|
|
Zheng Xiaoxuan,Sun Jiayuan,
|
自发荧光支气管镜在中央型支气管肺癌诊断中的临床分析
|
《临床肿瘤学杂志》
|
2014
|
19(4):346-349
|
|
Bo Jin, Yu Dong, Hui-min Wang, Jin-su Huang and Bao-hui Han
|
Correlation between serum CEA levels and EGFR mutations in Chinese nonsmokers with lung adenocarcinoma
|
Acta Pharmacologica Sinica
|
2014
|
35(3):373-80
|
|
Bai Hao, Qian JL,
|
S100A4 is an independent prognostic factor for patients with lung cancer: A meta-analysis
|
Genetic Testing and Molecular Biomarkers
|
2014
|
18(5):371-374
|
|
Rong Li, Yuqing Lou, Weiyan Zhang, Qianggang Dong ,
|
Vitamin D inhibition of lung adenocarcinoma cell proliferation in vitro
|
Tumor Biology
|
2014
|
35(11):10953–10958
|
|
Bo Jin, Yu Dong, Xueyan Zhang, Huimin Wang,
|
Association of XPC Polymorphisms and Lung Cancer Risk: A Meta-Analysis
|
PLoS One
|
2014
|
9(4): e93937
|
|
Wang Weimin,Chen Wenyi,Jiang Liyan,Wang Huimin,Shi Chunlei,Xiong Liwen,
|
盐酸埃克替尼治疗晚期非小细胞肺癌196例临床观察
|
《肿瘤学杂志》
|
2014
|
20(10):792-795
|
|
Zheng Xiaoxuan,Xiong Hongkai,Li Yong,Sun JiaYuan,
|
在YUV色彩空间中自荧光气管镜图像定量方法的临床应用
|
《中国肺癌杂志》
|
2014
|
17(11):797-803
|
|
Sun Jiayuan,Teng Jiajun,Zhong Runbo,Li Zhifu,Zhang Jie,Zhao Heng,
|
支气管内超声引导下经支气管针吸活检诊断胸内结核
|
《中华胸心血管外科杂志》
|
2014
|
30(11):653-656
|
|
Chu Tianqing,Teng Jiajun,Jiang Liyan,Zhong Hua,
|
Lung cancer-derived Dickkopf1 is associated with bone metastasis and the mechanism involves the inhibition of osteoblast differentiation.
|
Biochemical and Biophysical Research Communications
|
2014
|
443(3):962–968
|
|
Jiatao Lou, Suqin Ben, Guohua Yang, Xiaohui Liang, Xiaoqian Wang, Songshi Ni,
|
Quantification of Rare Circulating Tumor Cells in Non-Small Cell Lung Cancer by Ligand-Targeted PCR
|
Plos One
|
2013
|
8(12):e80458
|
|
Hao BAI,
|
手术在非小细胞肺癌单发脑转移治疗中?的作用分析
|
中国肺癌杂志
|
2013
|
6(12):646-50
|
|
Yuqing Lou, Rong Li, Liwen Xiong, Aiqin Gu, Chunlei Shi, Tianqing Chu, Xueyan Zhang, Ping Gu, Hua Zhong, Shaojun Wen ,
|
NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
|
Tumor Biology
|
2013
|
34(6):3967-79
|
|
Bo Yan, Wei Zhang, Fang Lu, Zhong–Lin Chen,, Li–Yan Jiang
|
Safety of polyethylene glycol recombinant human granulocyte colony-stimulating factor in treating non-small cell lung cancer patients at I b stage
|
Asian Pac J Trop Med
|
2013
|
6(11):912-5
|
|
Xueyan ZHANG, Huimin WANG, Bo JIN, Qianggang DONG, Jinsu HUANG,
|
肺腺癌组织中OCT4表达与患者临床指标及预后的相关性
|
中国肺癌杂志
|
2013
|
16(4):197-202
|
|
Chu TQ, Ding H, Garfield DH, Gu AQ, Pei J, Du WD,
|
Can determination of circulating endothelial cells and serum caspase-cleaved CK18 predict for response and survival in patients with advanced non-small-cell lung cancer receiving endostatin and paclitaxel-carboplatin chemotherapy? a retrospective study
|
J Thorac Oncol.
|
2013
|
7(12):1781-9
|
|
Xiaoming Tan, Qihan Wu, Yanyan Cai, Xueying Zhao, Shingming Wang, Zhiqiang Gao, Yang Yang, Xiaoying Li, Ji Qian, Jiucun Wang, Bo Su, Hongyan Chen,, Gening Jiangcorrespondenceemail, Daru Lu
|
Novel Association Between CD74 Polymorphisms and Hematologic Toxicity in Patients With NSCLC After Platinum-Based Chemotherapy
|
Clin Lung Cancer
|
2013
|
15(1):67-78.e12
|
|
Yang Huizhen,Teng Jiajun,Zhong Runbo,Zhang Jie,Sun Jiayuan,
|
气管内超声引导下经支气管针吸活检对肺内病变的诊断价值
|
中华结核和呼吸杂志
|
2013
|
36(1):17-21
|
|
Chun-Lei Shi, Rong Li, Li-Wen Xiong, Ai-Qin Gu, Bao-Hui Han ,
|
Lack of association between XRCC3 rs861539 (C > T) polymorphism and lung cancer risks: an update meta-analysis
|
Tumour Biol
|
2013
|
34(3):1819-24
|
|
Jiayuan Sun, Jiajun Teng, Huizhen Yang, Zhifu Li, Jie Zhang, Heng Zhao, David H. Garfield,,
|
Endobronchial ultrasound-guided transbronchial needle aspiration in diagnosing intrathoracic tuberculosis
|
Ann Thorac Surg
|
2013
|
96(6):2021-7
|
|
Shujun DAI, Youru LIU, Lin WANG,, Liyan JIANG
|
IV期肺腺癌二线EGFR-TKIs治疗失败后预后因素分析
|
中国肺癌杂志
|
2013
|
16(1):38-42
|
|
BO YE, WANG LI,JIAN FENG, JIAN-XIN SHI,YONG CHEN,
|
Treatment of pulmonary epithelioid hemangioendothelioma with combination chemotherapy: Report of three cases and review of the literature
|
Oncol Lett.
|
2013
|
5(5):1491-1496
|
|
Shaohua Gu, Qihan Wu, Xueying Zhao, Wenting Wu, Zhiqiang Gao, Xiaoming Tan, Ji Qian, Hongyan Chen, Yi Xie, Li Jin,, Daru Lu
|
Association of CASP3 polymorphism with hematologic toxicity in advanced NSCLC patients treated with platinum-based chemotherapy
|
Cancer Sci
|
2012
|
103(8):1451-9
|
|
Wenting Wu, Huan Li, Huibo Wang, Xueying Zhao, Zhiqiang Gao, Rong Qiao, Wei Zhang, Ji Qian, Jiucun Wang, Hongyan Chen, Qingyi Wei,
|
Effect of Polymorphisms in XPD on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients.
|
PLoS One
|
2012
|
7(3):e33200
|
|
Zhang L, Ma S, Song X,, Cheng Y, Huang C, Yang S, Liu X, Liu Y, Lu S, Wang J, Zhang S, Zhou C, Zhang X, Hayashi N, Wang M; on behalf of the INFORM investigators
|
Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial
|
Lancet Oncol
|
2012
|
13(5):466-475
|
|
Chu, Tian-Qing ; Ding, Hao; Garfield, David H ; Gu, Ai-Qin ; Pei, Jun ; Du,, Bao-Hui
|
Can Determination of Circulating Endothelial Cells and Serum Caspase-Cleaved CK18 Predict for Response and Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Endostatin and Paclitaxel-Carboplatin Chemotherapy? A Retrospective Study
|
J Thorac Oncol
|
2012
|
7(12):1781-9
|
|
Wu YL, Chu DT,, Liu X, Zhang L, Zhou C, Liao M, Mok T, Jiang H, Duffield E, Fukuoka M.
|
Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland China
|
Asia Pac J Clin Oncol
|
2012
|
8(3):232-43
|
|
Bai H,
|
The Effectiveness of Erlotinib Against Brain Metastases in Non-Small-cell Lung Cancer Patients.
|
Am J Clin Oncol
|
2012
|
|
|
Gao Z,, Wang H, Shi C, Xiong L, Gu A
|
Clinical observation of gefitinib as a first-line therapy in sixty-eight patients with advanced NSCLC
|
Oncol Lett
|
2012
|
3(5):1064-1068
|
|
Wei-feng Mao, Min-hua Shao, Pin-ting Gao, Ji Ma, Hui-juan Li, Gai-ling Li,
|
The important roles of RET, VEGFR2 and the RAF/MEK/ERK pathway in cancer treatment with sorafenib
|
Acta Pharmacologica Sinica
|
2012
|
33(10):1311-8
|
|
Rong Li ,Jing Wu ,Meili Ma ,Jun Pei ,Yiyi Song ,
Xueyan Zhang ,
|
Comparison of PG-SGA, SGA and body-composition
measurement in detecting malnutrition among newly diagnosed
lung cancer patients in stage IIIB/IV and benign conditions
|
Med Oncol
|
2011
|
28(3):689-96
|
|
Chun-Lei Shi, Xue-Yan Zhang,, Wei-Zhong He, Jie Shen and Tian-Qing Chu
|
A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.
|
Med Oncol
|
2011
|
28(4):1441-6
|
|
Jiayuan Sun, David H Garfield, Bing Lam, Jingjing Yan, Aiqin Gu, Jie Shen and Baohui Han
|
The Value of Autofluorescence Bronchoscopy Combined with White Light Bronchoscopy Compared with White Light Alone in the Diagnosis of Intraepithelial Neoplasia and Invasive Lung Cancer: A Meta-Analysis.
|
J Thorac Oncol
|
2011
|
6(8):1336-44
|
|
Zhong R, Teng J,, Zhong H
|
Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer
|
Cancer Immunol Immunother
|
2011
|
60(10):1497-502
|
|
, Gao G, Wu W, Gao Z, Zhao X, Li L, Qiao R, Chen H, Wei Q, Wu J, Lu D
|
Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients.
|
Lung Cancer
|
2011
|
72(2):238-43
|
|
ZHIQIANG GAO,, JIE SHEN, AIQIN GU, DAJIANG QI, JINSU HUANG, CHUNLEI SHI,
LIWEN XIONG, YIZHUO ZHAO, LIYAN JIANG, HUIMIN WANG and YURONG CHEN
|
ERCC1 protein as a guide for individualized therapy of late-stage advanced non-small cell lung cancer
|
Exp Ther Med
|
2011
|
2(5):811-815
|
|
, Baohui MD, PhD; Xiu, Qingyu MD, PhD; Wang, Huimin MD; Shen, Jie MD; Gu, Aiqin MD; Luo, Yi MD; Bai, Chunxue MD, PhD; Guo, Shuliang MD; Liu, Wenchao MD; Zhuang, Zhixiang MD; Zhang, Yang MD, PhD; Zhao, Yizhuo MD; Jiang, Liyan MD, PhD; Zhou, Jianying MD;
|
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung Cancer
|
Journal of Thoracic Oncology
|
2011
|
6(6):1104-9
|
|
Jiayuan Sun, Jian Zhang, Heng Zhao, Jie Shen, Aiqin Gu & Baohui Han
|
Role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma: Experience of a single institution in China
|
Thoracic Cancer
|
2010
|
|
|
Xueyan Zhang,, Jinsu Huang, Biqiang Zheng, Qin Geng, Fahad Aziz3and Qianggang Dong
|
Prognostic Significance of OCT4 Expression in Adenocarcinoma of the Lung
|
Jpn J Clin Oncol
|
2010
|
40(10):961-6
|
|
Gu Ping, Wang Hui-Min, Wang Wei-Min and Han Bao-Hui
|
Sunitinib in pretreated advanced non-small-cell lung carcinoma: a primary result from Asian population
|
Med Oncol
|
2010
|
28(2):578-83
|
|
Bo Jin, Ai-Mi Huang, Run-Bo Zhong and Bao-Hui Han
|
The Value of Tumor Markers in Evaluating Chemotherapy Response and Prognosis in Chinese Patients with Advanced Non-Small Cell Lung Cancer
|
Chemother
|
2010
|
56(6):417-423
|
|